Bill

HR 3091

Health Savings and Affordability for Fertility Act

119th Congress Introduced by Lauren Underwood

As introduced, HR 3091 only designates the Health Savings and Affordability for Fertility Act as the short title; no policy changes or fiscal provisions are included yet.

Introduced in House

WeVote Research Nonpartisan

Bill Summary · HR 3091

Summary of HR 3091 — Health Savings and Affordability for Fertility Act (HSA for Fertility Act)

This summary reflects the information provided for HR 3091 as introduced. The introduced text currently contains only a short-title designation, with no substantive policy provisions included in the version available.

Bill Details

Bill Number: HR 3091
Title: Health Savings and Affordability for Fertility Act (also referred to as the HSA for Fertility Act)
Introduced: April 30, 2025
Status: Introduced in the House; referred to the House Committee on Ways and Means
Classification: bill

Purpose and Short Title

The version content provided states: “This Act may be cited as the Health Savings and Affordability for Fertility Act or the HSA for Fertility Act.”
Current implication: The text available does not specify any substantive policy provisions, program changes, or fiscal measures. The stated purpose appears to be the designation of the act’s short title only.

Key Provisions (Substantive Content)

Provided text: None beyond the short-title designation. No statutory changes, funding levels, eligibility rules, or guidance are included in the version shared.
Implication: Without the full text, it is not possible to identify specific changes to Health Savings Accounts (HSAs) or fertility-related affordability provisions, nor to assess fiscal impact, eligibility, compliance, or effective dates.

Potential Impact (High-level, if enacted with substantive provisions)

Given the bill’s title, if later amended with substantive text, it could address aspects such as:
- Modifications to HSA-eligibility or permissible expenses related to fertility treatments or fertility-related services.
- Tax-advantaged treatment or expansion of allowable expenditures within HSAs for fertility care.
- Accessibility or affordability measures affecting individuals seeking fertility treatments.
Note: These potential impacts are speculative and depend on the actual statutory text enacted by Congress.

Procedural and Timeline Aspects

Introduction: April 30, 2025
Referral: House Committee on Ways and Means (typical for tax-related or revenue-related provisions)
Next steps: If the Committee advances the bill, it could move to further committee consideration, potential amendments, and, eventually, floor action in the House. The timing would depend on committee activity and legislative calendars.

Additional Information Needs

To provide a complete, accurate summary, the full text or a detailed summary of the bill’s provisions is required. Please share the enacted text, committee report, or any amendments for a comprehensive analysis of policy changes, fiscal impact, affected populations, and implementation timelines.

Compiled from official sources — confirm details with the bill’s official record.